Defining the earliest pathological changes of Alzheimer's disease
about
Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes.Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease.PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β.Ambient Glutamate Promotes Paroxysmal Hyperactivity in Cortical Pyramidal Neurons at Amyloid Plaques via Presynaptic mGluR1 Receptors.Dendrite regeneration of adult Drosophila sensory neurons diminishes with aging and is inhibited by epidermal-derived matrix metalloproteinase 2.
P2860
Defining the earliest pathological changes of Alzheimer's disease
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Defining the earliest pathological changes of Alzheimer's disease
@ast
Defining the earliest pathological changes of Alzheimer's disease
@en
Defining the earliest pathological changes of Alzheimer's disease
@nl
type
label
Defining the earliest pathological changes of Alzheimer's disease
@ast
Defining the earliest pathological changes of Alzheimer's disease
@en
Defining the earliest pathological changes of Alzheimer's disease
@nl
prefLabel
Defining the earliest pathological changes of Alzheimer's disease
@ast
Defining the earliest pathological changes of Alzheimer's disease
@en
Defining the earliest pathological changes of Alzheimer's disease
@nl
P2093
P2860
P1476
Defining the earliest pathological changes of Alzheimer's disease
@en
P2093
Alison J Canty
Anna E King
Carmen M Fernandez-Martos
Graeme H McCormack
James C Vickers
Mathew T Kirkcaldie
P2860
P304
P356
10.2174/1567205013666151218150322
P407
P5008
P577
2016-01-01T00:00:00Z